Global Over-The-Counter (OTC) Drugs Market – Size, Outlook, Trends and Forecast (2024 – 2032)

The Global Over-The-Counter drugs market was valued at USD XX million in 2018 and is projected to reach a value of USD XX million by 2024, registering a CAGR of XX%, during the forecast period 2018-2024. Over-the-counter(OTC) medicine is also known as OTC or nonprescription medicine. All these terms refer to that medicine because you can buy without a prescription. They are safe and effective when you follow the directions on the label and as directed by your healthcare professional.

Global Over-the-Counter (OTC) Drugs Market Share:

Compared to the past years, Over-the-Counter devices have undergone a predominant change in the markets of OTC. The Product Type segment is expected to have the highest growth rate. Among these, cough, cold and flu products grabbed more than 34% of the market share, globally.

Global Over-the-Counter (OTC) Drugs Market Size:

There is the wide range of Products in Over-the-Counter Drugs Market such as Cough and Cold, Vitamin, Minerals and Supplements, Analgesics, and Digestive Products. As there are enormous applications, the market size related to OTC is even bigger in  European countries.

Global Over-the-Counter (OTC) Drugs Market Growth:

Product Innovation, Increasing distribution channels for OTC drugs, Pharmaceutical companies switching to OTC from Rx drugs, Ease in advertising restrictions for these OTC drugs are major factors that propel or drive the growth of  Global Over-the-Counter(OTC) Drugs market.

Global Over-the-Counter (OTC) Drugs Market Industry Analysis:

The Global over-the-counter (OTC) drug market is segmented on the basis of product type and geography. On the product front, the market is further sub-segmented into different categories, such as analgesics, cough, cold and flu products, dermatological products, gastrointestinal products, vitamins, minerals, weight loss products, sleep aids, ophthalmic products, smoking cession aids, and other products.

Global Over-the-Counter (OTC) Drugs Market Outlook:

The switch from Rx to OTC refers to the transfer of proven prescription drugs to non-prescription drugs, and this can save money for the consumer. When nicotine replacement therapies became OTC drugs, the sales increased by 150-200% in the first year after the switch. Its increased access enabled thousands of people to use these therapies to quit smoking.

Global Over-the-Counter (OTC) Drugs Market Trends:

• Piramal Enterprises’ Consumer Products Division announced the acquisition of Digeplex and associated brands from Shreya Lifesciences. This acquisition strengthens Piramal’s position in the Gastro-Intestinal (GI) segment and is complementary to its existing brands -Polycrol and Naturolax, in the GI segment.
• Dr. Reddy’s Laboratories Ltd announced that it has launched Melphalan Hydrochloride for Injection, a therapeutic equivalent generic version of Alkeran for Injection in the United States market approved by the U.S. Food and Drug Administration (USFDA).

Global Over-the-Counter (OTC) Drugs Market Research report includes:

• An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
• To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
• Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year–On–Year
• Identifying DROC in the current market and their impact in altering the market dynamics.
• Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial analysis with major competitors.
• Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
• Identify the latest developments, market shares and strategies that are employed by the major market players, such as
• Reddy’s Laboratories
• Piramal
• Takeda
• Pfizer
• GlaxoSmithKline